| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.66▼ | 3.67▼ | 3.68▼ | 3.41▲ | 3.51▲ |
| MA10 | 3.67▼ | 3.70▼ | 3.80▼ | 3.39▲ | 4.04▼ |
| MA20 | 3.68▼ | 3.83▼ | 3.63▲ | 3.42▲ | 4.10▼ |
| MA50 | 3.69▼ | 3.51▲ | 3.40▲ | 4.07▼ | 3.16▲ |
| MA100 | 3.81▼ | 3.40▲ | 3.43▲ | 4.06▼ | 2.21▲ |
| MA200 | 3.69▼ | 3.43▲ | 3.68▼ | 3.45▲ | 1.85▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.045▼ | -0.025▼ | 0.066▲ | -0.185▼ |
| RSI | 42.863▼ | 46.807▼ | 54.088▲ | 50.799▲ | 48.809▼ |
| STOCH | 46.343 | 14.319▼ | 8.281▼ | 33.334 | 14.768▼ |
| WILL %R | -58.333 | -91.781▼ | -95.161▼ | -48.988 | -74.021 |
| CCI | -66.388 | -73.869 | -110.788▼ | 129.525▲ | -78.965 |
| ▼ GAP | $PGEN Open Gap Down %2 | Set Alert |
|
Thursday, March 26, 2026 06:09 AM
Precigen (PGEN) stock jumps despite underwhelming 2025 financials as analysts cheer the company's Q1 outlook boosted by its cancer drug Papzimeos. Read more here.
|
|
Thursday, March 26, 2026 05:07 AM
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 Earnings Call Transcript March 25, 2026 Precigen, Inc. misses on earnings expectations. Reported EPS is $-0.07509 EPS, expectations were $-0.075. Operator: Good ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/03/26 | 3.80 | 4.00 | 3.62 | 3.67 | 7,040,855 |
| 26/03/26 | 4.065 | 4.275 | 3.73 | 3.89 | 23,337,914 |
| 25/03/26 | 3.10 | 3.25 | 3.04 | 3.10 | 5,959,675 |
| 24/03/26 | 3.20 | 3.23 | 3.05 | 3.13 | 5,144,758 |
| 23/03/26 | 3.34 | 3.37 | 3.23 | 3.24 | 3,029,446 |
| 20/03/26 | 3.26 | 3.38 | 3.23 | 3.28 | 2,908,325 |
| 19/03/26 | 3.24 | 3.36 | 3.11 | 3.32 | 4,021,628 |
| 18/03/26 | 3.48 | 3.54 | 3.265 | 3.27 | 4,013,141 |
| 17/03/26 | 3.51 | 3.57 | 3.46 | 3.54 | 1,706,451 |
| 16/03/26 | 3.55 | 3.64 | 3.50 | 3.51 | 1,810,329 |
|
|
||||
|
|
||||
|
|